Testicular and para-testicular tumors in south western Nigeria.
BACKGROUND
Tumors of the testis and paratesticular tissues are rare, especially in men of African descent. In recent reviews however, the incidence is rising among the Caucasians and black Americans. We set out to determine the incidence in South-Western Nigeria and to examine the histopathologic variants.


METHODS
A retrospective study of patients who had histopathologically confirmed testicular and para-testicular tumours between 1989 and 2005 (17 years). Their records were documented at the Ife-Ijesha cancer registry which serves 4.7 million men residing in three states of South-Western Nigeria.


RESULTS
There were 26 cases of testicular and para-testicular tumors with an average incidence of 1.5 cases per year. The incidence of testicular cancer in our study was 0.55 per 100,000 population (95% CI, 0.52-0.57) and accounted for 1.1% of all male cancers. Rhabdomyosarcomas were the most common variety (70% of the paratesticular tumors and 26.8% of all tumors of the testis). Seminomas comprised 50% of the germ cell tumors and 15.4% of all testicular tumors in this series.


CONCLUSIONS
There still remains a low incidence of testis cancer in the South Western Nigeria. The reduction in the incidence of seminomas makes rhabdomyosarcomas the most predominant tumor in South Western Nigeria.
Salako
A A
AA
Department of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Onakpoya
U U
UU
Osasan
S A
SA
Omoniyi-Esan
G O
GO
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D002648:Child; D002675:Child, Preschool; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000453:epidemiology* / Q000473:pathology*; D009549:Nigeria / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D013736:Testicular Neoplasms / Q000453:epidemiology* / Q000473:pathology*; D055815:Young Adult
Hum Reprod. 2001 May;16(5):1007-11
11331652
Can J Surg. 1981 Jul;24(4):353-5
6115708
Natl Cancer Inst Monogr. 1979 Nov;(53):157-64
231740
CMAJ. 1999 Jan 26;160(2):201-5
9951441
BJU Int. 2001 Mar;87(4):361-5
11251531
East Afr Med J. 1995 Sep;72(9):554-6
7498039
Br J Urol. 1992 Dec;70(6):656-9
1362513
Indian J Cancer. 1970 Jun;7(2):98-109
5507065
Int J Urol. 2006 Feb;13(2):186-8
16563149
J Urol. 1967 Dec;98(6):701-5
5625086
West Indian Med J. 1990 Mar;39(1):35-8
2333696
Int J Cancer. 1996 Mar 15;65(6):723-9
8631581
Br J Urol. 1982 Aug;54(4):411-4
7116107
East Afr Med J. 2000 Feb;77(2):80-5
10774080
Int J Cancer. 2003 Oct 10;106(6):934-41
12918073
Cancer. 1991 Jul 1;68(1):211-9
1646683
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2157-66
15598775
Br J Cancer. 1986 Apr;53(4):501-5
3707843
Cancer. 2003 Jan 1;97(1):63-70
12491506
BMJ. 1992 Sep 12;305(6854):609-13
1393072
East Afr Med J. 1978 May;55(5):205-10
699828